Supernus Pharmaceuticals SUPN Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's operating lease ROU assets?
- Supernus Pharmaceuticals (SUPN) reported operating lease ROU assets of $26.4M in Q1 2026.
- How has Supernus Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Supernus Pharmaceuticals's operating lease ROU assets increased by 16.2% year-over-year, from $22.72M to $26.4M.
- What is the long-term trend for Supernus Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's operating lease ROU assets has grown at a 5.7% compound annual growth rate (CAGR), from $20.23M to $26.71M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.